Katy Beckermann

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Katy Beckermann
Apr 20, 2025, 02:48 | Blog
Katy Beckermann: New Paper in Nature Cancer - UnitedMet Enables Metabolic Profiling from RNA-Seq
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, posted on X: "Exciting…
Apr 1, 2025, 09:47 | Science
Giulia Claire Giudice: Strategies for RCC patients progressing on ICIs
Giulia Claire Giudice, Medical Doctor at University Hospital of Parma, shared an article on X: "Newly…
Apr 1, 2025, 04:49 | Blog
Katy Beckermann: Secondary Analysis of the TITAN Trial
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, posted on X: "New…
Mar 17, 2025, 16:53 | Blog
Katy Beckermann: Excited to see the impact of a new care coordinator role for bladder cancer
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post on…
Feb 16, 2025, 04:20 | Societies
Highlights From Day 3 of ASCOGU25
The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society of Clinical…
Jan 27, 2025, 15:54 | Blog
Katy Beckermann: We NEED the NIH to keep advancing research
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post by…
Jan 9, 2025, 10:58 | Insight
Katy Beckermann: Grateful for the 20 wonderful years at Vanderbilt-Ingram Cancer Center
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post on…
Dec 3, 2024, 18:58 | Blog
Katy Beckermann: The role of belzutifan in treating rare mutation VHL congenital-related polycythemia
Katy Beckermann, Assistant Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine,…
Nov 11, 2024, 11:50 | Societies
Highlights from the 39th Society for Immunotherapy of Cancer Annual Meeting
The 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting was held from November 6–10, 2024,…
Oct 11, 2024, 16:17 | Blog
Katy Beckermann: Defining oligometastatic RCC is challenging
Katy Beckermann, Assistant Professor Of Medicine at Vanderbilt University Medical Center, shared a post on…
Sep 18, 2024, 11:25 | Insight
Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…
Aug 30, 2024, 16:32 | Blog
Katy Beckermann: Feasibility of an intermittent ipi/nivo approach in their Phase II trial
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X:…
Aug 15, 2024, 18:25 | Blog
Katy Beckermann: Kidney Cancer Association's Virtual Patient Symposium
Kidney Cancer Association's Virtual Patient Symposium aims to educate patients, caregivers, and the public about…
Jun 27, 2024, 05:29 | Blog
Chandler Park: An honor to co-host with Cathy Eng for the ASCO24 Nashville review
Chandler Park shared on LinkedIn:     . “That was FUN! It was an honor to…
Apr 17, 2024, 19:02 | Blog
Katy Beckermann: Exciting update from Dr. Mike Atkins on the novel checkpoint inhibitor LAG3 and its potential role in kidney cancer treatment
Katy Beckermann, Assistant Professor at Vanderbilt University Medical Center, shared a post by GU Oncology…
All: 15 Posts: 1 - 100
Special Coverage